This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Sorry! 

It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later - or visit our Novo Nordisk Science Hub congress overview in the meantime.

Current treatment strategies, unmet medical need, FLOW rationale

FLOW trial design and baseline characteristics, glycaemic control and body weight

FLOW kidney outcomes

FLOW CV outcomes

FLOW results by baseline use of SGLT2i

FLOW results – summary and clinical implication